Clinical trials
Withdrawn Infections trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
67 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2006 | 2 |
| 2008 | 3 |
| 2009 | 3 |
| 2010 | 2 |
| 2011 | 10 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 3 |
| 2016 | 6 |
| 2017 | 4 |
| 2018 | 5 |
| 2019 | 4 |
| 2020 | 4 |
| 2021 | 4 |
| 2022 | 4 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 67 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Brigham and Women's Hospital | 3 |
| M.D. Anderson Cancer Center | 2 |
| NYU Langone Health | 2 |
| Neogenix, LLC dba Ogenix | 2 |
| Pfizer | 2 |
| University Hospital, Limoges | 2 |
| University of Minnesota | 2 |
| ViiV Healthcare | 2 |
| Wyeth is now a wholly owned subsidiary of Pfizer | 2 |
| AM-Pharma | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Infections | 67 |
| Acquired Immunodeficiency Syndrome | 6 |
| Neoplasms | 4 |
| Neutropenia | 4 |
| Burkitt Lymphoma | 3 |
| COVID-19 | 3 |
| Inflammation | 3 |
| Leukemia | 3 |
| Lymphoma | 3 |
| Lymphoma, Large B-Cell, Diffuse | 3 |
Trials
Showing 1 to 25 of 67. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.